Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
9.87
Dollar change
+0.27
Percentage change
2.81
%
IndexRUT P/E- EPS (ttm)-3.92 Insider Own35.54% Shs Outstand134.78M Perf Week5.34%
Market Cap1.36B Forward P/E- EPS next Y-3.72 Insider Trans-0.05% Shs Float88.78M Perf Month30.04%
Income-533.34M PEG- EPS next Q-0.86 Inst Own50.05% Short Float6.44% Perf Quarter16.12%
Sales78.62M P/S17.29 EPS this Y16.32% Inst Trans-0.36% Short Ratio6.32 Perf Half Y1.02%
Book/sh9.08 P/B1.09 EPS next Y3.05% ROA-30.10% Short Interest5.72M Perf Year21.25%
Cash/sh7.29 P/C1.35 EPS next 5Y7.00% ROE-36.58% 52W Range7.12 - 13.09 Perf YTD-1.89%
Dividend Est.- P/FCF- EPS past 5Y-34.12% ROI-39.98% 52W High-24.60% Beta0.55
Dividend TTM- Quick Ratio8.94 Sales past 5Y421.39% Gross Margin78.24% 52W Low38.62% ATR (14)0.49
Dividend Ex-DateNov 03, 2010 Current Ratio8.94 EPS Y/Y TTM12.57% Oper. Margin-688.05% RSI (14)70.45 Volatility5.81% 5.68%
Employees587 Debt/Eq0.09 Sales Y/Y TTM-33.82% Profit Margin-678.40% Recom1.78 Target Price29.88
Option/ShortYes / Yes LT Debt/Eq0.08 EPS Q/Q-28.52% Payout- Rel Volume0.90 Prev Close9.60
Sales Surprise-57.04% EPS Surprise-48.22% Sales Q/Q-9.81% EarningsOct 31 AMC Avg Volume905.32K Price9.87
SMA2018.41% SMA5024.60% SMA2007.13% Trades Volume817,386 Change2.81%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Downgrade JP Morgan Overweight → Neutral $23 → $9
Sep-08-23Downgrade BofA Securities Buy → Neutral $23 → $14
Mar-06-23Upgrade JP Morgan Neutral → Overweight $35 → $34
Feb-21-23Upgrade Goldman Neutral → Buy $41 → $53
Jan-27-23Upgrade Morgan Stanley Underweight → Equal-Weight $18 → $30
Sep-14-22Initiated SVB Leerink Outperform $40
Sep-09-22Initiated Morgan Stanley Underweight $15
Mar-03-22Upgrade Robert W. Baird Underperform → Neutral $36 → $28
Dec-21-21Downgrade Robert W. Baird Neutral → Underperform $36
Oct-25-21Upgrade JP Morgan Underweight → Neutral $29 → $37
Nov-01-24 05:01PM
12:04AM
Oct-31-24 05:20PM
04:05PM
Oct-18-24 03:04PM
04:30PM Loading…
Oct-17-24 04:30PM
Oct-15-24 08:16AM
Oct-03-24 04:00PM
Sep-10-24 08:05AM
Sep-09-24 04:05PM
Sep-04-24 08:30AM
Aug-22-24 08:05AM
Aug-06-24 09:55AM
Aug-01-24 05:50PM
04:02PM
04:01PM Loading…
04:01PM
Jul-18-24 04:05PM
Jul-04-24 10:01AM
Jun-26-24 08:05AM
Jun-06-24 01:26PM
Jun-05-24 02:51PM
05:30AM
May-29-24 04:05PM
08:05AM
May-23-24 04:05PM
May-22-24 08:05AM
May-21-24 08:17AM
May-13-24 07:21PM
May-09-24 10:46AM
May-07-24 09:55AM
01:05PM Loading…
May-03-24 01:05PM
06:05AM
04:06AM
May-02-24 09:56PM
06:05PM
04:05PM
Apr-30-24 04:05PM
Apr-24-24 12:00PM
Apr-18-24 08:00AM
Apr-11-24 04:30PM
Apr-04-24 07:01PM
Mar-22-24 07:00AM
Mar-19-24 02:58PM
Mar-13-24 11:07AM
Mar-05-24 08:05AM
Feb-23-24 01:54PM
10:34AM
09:55AM
08:05AM
Feb-22-24 05:50PM
04:05PM
Feb-20-24 04:30PM
Feb-14-24 03:45PM
Feb-01-24 04:05PM
Jan-15-24 11:32AM
Dec-17-23 07:00AM
07:00AM
Dec-13-23 04:05PM
Dec-06-23 04:05PM
Nov-30-23 06:10AM
Nov-13-23 08:00AM
Nov-10-23 08:00AM
Nov-08-23 08:05AM
Nov-04-23 11:42AM
Nov-03-23 09:02AM
Nov-02-23 07:00PM
04:05PM
Oct-30-23 08:00AM
Oct-23-23 02:50AM
Oct-12-23 04:05PM
Oct-11-23 08:00AM
Oct-05-23 04:30PM
Oct-03-23 07:59AM
Sep-20-23 08:00AM
Sep-19-23 05:07AM
Sep-08-23 09:34AM
Aug-29-23 04:30PM
Aug-12-23 11:05AM
Aug-11-23 10:15AM
Aug-07-23 06:03AM
Aug-04-23 01:40PM
Aug-03-23 06:05PM
04:05PM
Jul-26-23 04:05PM
Jul-21-23 10:11AM
Jul-20-23 04:50PM
11:31AM
08:00AM
Jun-29-23 09:00AM
Jun-25-23 08:00AM
Jun-24-23 05:30AM
Jun-21-23 08:00PM
Jun-07-23 02:13AM
Jun-05-23 04:05PM
May-17-23 04:05PM
May-16-23 09:25AM
May-15-23 08:35AM
08:00AM
May-11-23 08:30AM
May-10-23 02:07PM
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
de Verneuil VaninaEVP and General CounselNov 06 '24Sale10.114,39744,45456,973Nov 07 07:20 PM
VANINA DE VERNEUILOfficerNov 06 '24Proposed Sale9.644,39742,387Nov 06 04:55 PM
de Verneuil VaninaEVP and General CounselNov 05 '24Sale9.472,34722,22561,370Nov 05 05:51 PM
de Verneuil VaninaEVP and General CounselNov 01 '24Sale7.201,40310,10763,717Nov 05 05:51 PM
VANINA DE VERNEUILOfficerNov 05 '24Proposed Sale9.372,34721,991Nov 05 04:23 PM
Napolitano JanetDirectorSep 09 '24Sale7.8012,19095,03211,616Sep 10 04:28 PM
JANET ANN NAPOLITANO DirectorSep 09 '24Proposed Sale7.7612,19094,594Sep 09 04:29 PM
Ramasastry SairaDirectorJun 11 '24Sale10.954,00043,78914,619Jun 12 12:21 PM
De Backer MarianneChief Executive OfficerApr 03 '24Sale9.4672,995690,365678,457Apr 04 04:14 PM
HANLY ANN M.EVP & Chief Technology OfficerApr 01 '24Sale10.052,71127,251132,069Apr 02 08:58 PM
Lee SungEVP & Chief Financial OfficerMar 27 '24Sale9.896,00859,404100,492Mar 28 12:18 PM
HANLY ANN M.EVP & Chief Technology OfficerFeb 22 '24Sale10.0512,296123,521134,780Feb 26 07:34 PM
Pang PhillipEVP & Chief Medical OfficerFeb 22 '24Sale10.0514,568146,344250,111Feb 26 07:31 PM
SCANGOS GEORGE ADirectorFeb 26 '24Sale11.6517,722206,522112,989Feb 26 07:30 PM
SCANGOS GEORGE ADirectorFeb 22 '24Sale10.0510,028100,737130,711Feb 26 07:30 PM
SCANGOS GEORGE ADirectorFeb 20 '24Sale10.2216,872172,385140,739Feb 20 09:02 PM
SCANGOS GEORGE ADirectorFeb 16 '24Sale10.2410,878111,386157,611Feb 20 09:02 PM
Pang PhillipEVP & Chief Medical OfficerFeb 16 '24Sale10.243,32134,006264,679Feb 16 06:56 PM
Pang PhillipEVP & Chief Medical OfficerJan 02 '24Option Exercise1.3880,000110,299268,000Jan 03 02:47 PM